GOSS: Gossamer Bio, Inc. Stock

by  •  • Comments Off on GOSS: Gossamer Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 253.44
Enterprise Value ($M) 422.18
Book Value ($M) -6.25
Book Value / Share -0.03
Price / Book -40.55
NCAV ($M) -11.36
NCAV / Share -0.05
Price / NCAV -22.30

Profitability (mra)
Return on Invested Capital (ROIC) -0.26
Return on Assets (ROA) -0.20
Return on Equity (ROE) -1.92

Liquidity (mrq)
Quick Ratio 5.71
Current Ratio 5.71

Balance Sheet (mrq) ($M)
Current Assets 275.48
Assets 280.59
Liabilities 286.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 114.70
Operating Income -59.92
Net Income -56.53
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -3.47
Cash from Investing 29.02
Cash from Financing -11.49

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Invus Global Management, LLC 2.80 -56.33
02-05 13G Octagon Capital Advisors LP 8.60
01-30 13G/A Vanguard Group Inc 4.42 -13.76
11-12 13G/A Fmr Llc 3.51 -35.29

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-15 10-Q – UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI
2024-11-07 10-Q – UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-12 10-Q – UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 214,060 1,031,026 20.76
2025-05-29 173,406 935,226 18.54
2025-05-28 136,703 779,748 17.53
2025-05-27 210,038 1,103,619 19.03

(click for more detail)

Similar Companies
GERN – Geron Corporation GILD – Gilead Sciences, Inc.
GLUE – Monte Rosa Therapeutics, Inc. HALO – Halozyme Therapeutics, Inc.
HLVX – HilleVax, Inc.


Financial data and stock pages provided by
Fintel.io